The U.S. Food and Drug Administration today approved Gilenya (fingolimod) to treat relapsing multiple sclerosis (MS) in children and adolescents age 10 years...
Tag - treat multiple sclerosis
Press Releases
Timeless Medical Systems® appoints Mike Antonelli as VP of Technology to drive next-generation platform innovation
Luma acquires Tonic to support 1,000+ health systems and 100M patients
HealthTree adds Flatiron Health and CareSpace EHR connections
DSS Wins CTM Plus Contract from U.S. Department of Veterans Affairs
